CEO Exit Spurs Health Catalyst Stock Slip

Health Catalyst shares are trading lower after Cantor Fitzgerald downgraded its rating to Neutral with a price target decrease from $9.00 to $4.00 following the announcement of CEO Dan Burton's upcoming retirement.